Search: id:"swepub:oai:DiVA.org:liu-63266" >
Chelation of lysoso...
-
Berndt, CarstenKarolinska Institutet
(author)
Chelation of lysosomal iron protects against ionizing radiation.
- Article/chapterEnglish2010
Publisher, publication year, extent ...
-
2010
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:DiVA.org:liu-63266
-
https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-63266URI
-
https://doi.org/10.1042/BJ20100996DOI
-
http://kipublications.ki.se/Default.aspx?queryparsed=id:121634909URI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Original Publication: Carsten Berndt, Tino Kurz, Markus Selenius, Aristi P Fernandes, Margareta R Edgren and Ulf T Brunk, Chelation of lysosomal iron protects against ionizing radiation., 2010, Biochemical Journal, (432), 2, 295-301. http://dx.doi.org/10.1042/BJ20100996 Copyright: Portland Press -- London http://www.portlandpress.com/
-
Ionizing radiation causes DNA damage and consequent apoptosis, mainly due to the production of hydroxyl radicals (HO•) that follows radiolytic splitting of water. However, superoxide (O2•-) and H2O2 also form and induce oxidative stress with resulting LMP (lysosomal membrane permeabilization) arising from iron-catalysed oxidative events. The latter will contribute significantly to radiation-induced cell death and its degree largely depends on the quantities of lysosomal redox-active iron present as a consequence of autophagy and endocytosis of iron-rich compounds. Therefore radiation sensitivity might be depressed by lysosome-targeted iron chelators. In the present study, we have shown that cells in culture are significantly protected from ionizing radiation damage if initially exposed to the lipophilic iron chelator SIH (salicylaldehyde isonicotinoyl hydrazone), and that this effect is based on SIH-dependent lysosomal stabilization against oxidative stress. According to its dose-response-modifying effect, SIH is a most powerful radioprotector and a promising candidate for clinical application, mainly to reduce the radiation sensitivity of normal tissue. We propose, as an example, that inhalation of SIH before each irradiation session by patients undergoing treatment for lung malignancies would protect normally aerated lung tissue against life-threatening pulmonary fibrosis, whereas the sensitivity of malignant lung tumours, which usually are non-aerated, will not be affected by inhaled SIH.
Subject headings and genre
-
ionizing radiation
-
iron chelation
-
lung cancer
-
lysosome
-
oxidative stress
-
salicylaldehyde isonicotinoyl hydrazone (SIH).
-
MEDICINE
-
MEDICIN
Added entries (persons, corporate bodies, meetings, titles ...)
-
Kurz, TinoLinköpings universitet,Farmakologi,Hälsouniversitetet,medicin(Swepub:liu)tinku34
(author)
-
Selenius, MarkusDivision of Pathology, Department of Laboratory Medicineand Division of Medical Radiation Physics, Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden,medicine
(author)
-
Fernandes, Aristi PKarolinska Institutet
(author)
-
Edgren, Margareta RKarolinska Institutet
(author)
-
Brunk, Ulf TLinköpings universitet,Farmakologi,Hälsouniversitetet,medicin(Swepub:liu)ulfbr20
(author)
-
Karolinska InstitutetFarmakologi
(creator_code:org_t)
Related titles
-
In:Biochemical Journal432:2, s. 295-3010264-60211470-8728
Internet link
Find in a library
To the university's database